Efficacy and Safety of Ritalin ® LA™, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

Author： Biederman J.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.5, Iss.12, 2003-01, pp. : 833-841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Efficacy of Two Once Daily Methylphenidate Formulations (Ritalin ® LA™ and Concerta ® ) and Placebo in Children with Attention Deficit Hyperactivity Disorder Across the School Day

By Lopez Frank  

Pediatric Drugs, Vol. 5, Iss. 8, 2003-01 ,pp. : 545-555

Adis International

Access to resources Recommend Favorite

Extended-Release Methylphenidate (Ritalin LA)

By Lyseng-Williamson K.A.   Keating G.M.  

Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. : 2251-2259

Adis International

Access to resources Recommend Favorite

Guanfacine Extended-Release: In Attention Deficit Hyperactivity Disorder

By Muir Victoria J.   Perry Caroline M.  

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1693-1702

Adis International

Access to resources Recommend Favorite

Clonidine Extended-Release: In Attention-Deficit Hyperactivity Disorder

By Croxtall Jamie D.  

Pediatric Drugs, Vol. 13, Iss. 5, 2011-10 ,pp. : 329-336

Adis International

Access to resources Recommend Favorite

Effect of Switching Drug Formulations from Immediate-Release to Extended-Release OROS Methylphenidate: A Chart Review of Spanish Adults with Attention-Deficit Hyperactivity Disorder

By Josep Antoni Ramos-Quiroga   Bosch Rosa   Castells Xavier   Valero Sergi   Nogueira Mariana   Gómez Nuria   Yelmo Silvia   Ferrer Marc   Martínez Yolanda   Casas Miguel  

CNS Drugs, Vol. 22, Iss. 7, 2008-01 ,pp. : 603-611

Adis International

Access to resources Recommend Favorite